by John Finey | Mar 18, 2019 | Blog
With everything going on at the moment it is easy to forget that there are things other than Brexit happening. An important one for the pharma supply chain is the scheduling of Pregabalin and Gabapentin as Class C, schedule 3 controlled drugs from 1st April 2019….
by John Finey | Aug 21, 2018 | Blog, Brexit, Training
I am sure plenty has been written and said about what I am sure many will see as an additional burden on wholesalers, this simple post is to help provide clarity about the scope of the regulations…
by John Finey | Jun 11, 2018 | Blog, Brexit, MHRA, NHS
There have been major regulatory changes within the Medical Device market, with more coming in the form of the Medical Device Regulations (MDR) which is in the process of being implemented at the moment. The main change that has affected the market over the last...
by John Finey | Feb 2, 2018 | Behind the scenes, Blog, Brexit, Business, public speaking
Following a bun fight between 19 EU countries and a failure to agree on the new location of the EMA within the group of EU foreign ministers the decision was made by tossing a coin, at least it wasn’t ‘Rock, Paper, Scissors’! Amsterdam won through meaning that...
by John Finey | Jan 8, 2018 | Blog, Pharmacist
Scenario 1 Patient asks for advice about travelling with medication to a north African resort for three weeks and wanted to know how they should best store their medication. Given that they had been told that their accommodation included a fridge the patient asked...
